stockportfolio.pro
Stocks / ABSI vs EYPT
ABSI vs EYPT
Absci Corporation and EyePoint, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Absci Corporation (ABSI) | EyePoint, Inc. (EYPT) | |
|---|---|---|
| Market cap | $1.0B | $1.0B |
| Revenue (latest FY) | $2.80M | $31.37M |
| Net income (latest FY) | $-115.18M | $-231.96M |
| Revenue growth (5y CAGR) | -10.1% | -1.8% |
| Net margin | -4113.7% | -739.4% |
| Return on equity | -60.8% | -75.8% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ABSI — free Open EYPT — freeFrequently asked questions
Which is bigger, ABSI or EYPT?
EyePoint, Inc. is larger by market capitalization — $1.0B versus $1.0B.
Which grows faster, ABSI or EYPT?
Over the last five fiscal years, EyePoint, Inc. grew revenue faster — -1.8%/yr versus -10.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.